Concepts (69)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Congenital Microtia | 4 | 2020 | 26 | 2.210 |
Why?
|
| Hearing Aids | 4 | 2020 | 31 | 2.110 |
Why?
|
| Bone Conduction | 3 | 2020 | 6 | 1.510 |
Why?
|
| Down Syndrome | 2 | 2024 | 201 | 1.320 |
Why?
|
| Congenital Abnormalities | 3 | 2020 | 300 | 1.250 |
Why?
|
| Tympanoplasty | 2 | 2024 | 11 | 1.050 |
Why?
|
| Hearing Loss, Conductive | 3 | 2020 | 16 | 0.980 |
Why?
|
| Tympanic Membrane Perforation | 1 | 2024 | 1 | 0.870 |
Why?
|
| Ear | 2 | 2020 | 27 | 0.820 |
Why?
|
| Cholesteatoma, Middle Ear | 1 | 2022 | 13 | 0.740 |
Why?
|
| Tongue Neoplasms | 1 | 2020 | 30 | 0.660 |
Why?
|
| Ear Auricle | 1 | 2020 | 5 | 0.650 |
Why?
|
| Hamartoma | 1 | 2020 | 49 | 0.650 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2020 | 65 | 0.640 |
Why?
|
| Referral and Consultation | 1 | 2020 | 557 | 0.490 |
Why?
|
| Prevalence | 4 | 2024 | 2583 | 0.400 |
Why?
|
| Electrocoagulation | 1 | 2021 | 32 | 0.340 |
Why?
|
| Hearing Tests | 2 | 2020 | 16 | 0.330 |
Why?
|
| Retrospective Studies | 8 | 2024 | 16928 | 0.320 |
Why?
|
| Ear, Middle | 1 | 2018 | 24 | 0.290 |
Why?
|
| Heart Defects, Congenital | 1 | 2020 | 1848 | 0.290 |
Why?
|
| Laryngoplasty | 1 | 2018 | 26 | 0.290 |
Why?
|
| Tinnitus | 1 | 2018 | 23 | 0.290 |
Why?
|
| Myoclonus | 1 | 2018 | 32 | 0.290 |
Why?
|
| Urogenital Abnormalities | 1 | 2020 | 160 | 0.280 |
Why?
|
| Neuromuscular Agents | 1 | 2018 | 65 | 0.270 |
Why?
|
| Infant | 5 | 2024 | 12761 | 0.270 |
Why?
|
| Patient Admission | 1 | 2018 | 170 | 0.270 |
Why?
|
| Child | 7 | 2024 | 25086 | 0.250 |
Why?
|
| Postoperative Care | 1 | 2018 | 306 | 0.250 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2018 | 162 | 0.240 |
Why?
|
| Kidney Diseases | 1 | 2020 | 479 | 0.230 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2018 | 472 | 0.220 |
Why?
|
| Middle Ear Ventilation | 1 | 2024 | 37 | 0.210 |
Why?
|
| Humans | 13 | 2024 | 126518 | 0.210 |
Why?
|
| Kidney | 1 | 2020 | 1282 | 0.200 |
Why?
|
| Mastoid | 1 | 2022 | 25 | 0.190 |
Why?
|
| Child, Preschool | 3 | 2024 | 14338 | 0.180 |
Why?
|
| Immunization | 1 | 2023 | 301 | 0.180 |
Why?
|
| Data Collection | 1 | 2023 | 367 | 0.170 |
Why?
|
| Male | 7 | 2024 | 62339 | 0.170 |
Why?
|
| Ichthyosiform Erythroderma, Congenital | 1 | 2020 | 4 | 0.170 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 1 | 2020 | 24 | 0.160 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2020 | 78 | 0.160 |
Why?
|
| Limb Deformities, Congenital | 1 | 2020 | 109 | 0.150 |
Why?
|
| Tertiary Care Centers | 1 | 2020 | 246 | 0.150 |
Why?
|
| Female | 7 | 2024 | 68161 | 0.150 |
Why?
|
| Diagnostic Imaging | 1 | 2020 | 278 | 0.150 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2020 | 155 | 0.140 |
Why?
|
| Otolaryngology | 1 | 2020 | 114 | 0.140 |
Why?
|
| Neonatal Screening | 1 | 2020 | 190 | 0.140 |
Why?
|
| Treatment Outcome | 2 | 2024 | 12501 | 0.130 |
Why?
|
| Echocardiography | 1 | 2020 | 1111 | 0.110 |
Why?
|
| Abnormalities, Multiple | 1 | 2020 | 965 | 0.110 |
Why?
|
| Adolescent | 2 | 2024 | 19976 | 0.110 |
Why?
|
| Risk Factors | 1 | 2024 | 10512 | 0.080 |
Why?
|
| Palatal Muscles | 1 | 2018 | 2 | 0.070 |
Why?
|
| Tenotomy | 1 | 2018 | 3 | 0.070 |
Why?
|
| Airway Management | 1 | 2018 | 68 | 0.070 |
Why?
|
| Syndrome | 1 | 2020 | 1133 | 0.070 |
Why?
|
| Infant, Newborn | 1 | 2020 | 8357 | 0.060 |
Why?
|
| Feasibility Studies | 1 | 2018 | 792 | 0.060 |
Why?
|
| Ultrasonography | 1 | 2020 | 936 | 0.060 |
Why?
|
| Mass Screening | 1 | 2020 | 806 | 0.050 |
Why?
|
| Comorbidity | 1 | 2018 | 1547 | 0.050 |
Why?
|
| Length of Stay | 1 | 2018 | 1342 | 0.050 |
Why?
|
| Incidence | 1 | 2020 | 3239 | 0.050 |
Why?
|
| Texas | 1 | 2020 | 3548 | 0.040 |
Why?
|
| Quality of Life | 1 | 2020 | 2026 | 0.040 |
Why?
|